These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35716462)

  • 1. Mass spectrometry-based ganglioside profiling provides potential insights into Alzheimer's disease development.
    Li H; Liu Y; Wang Z; Xie Y; Yang L; Zhao Y; Tian R
    J Chromatogr A; 2022 Aug; 1676():463196. PubMed ID: 35716462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype-related changes of ganglioside composition in brain regions of transgenic mouse models of Alzheimer's disease.
    Barrier L; Ingrand S; Damjanac M; Rioux Bilan A; Hugon J; Page G
    Neurobiol Aging; 2007 Dec; 28(12):1863-72. PubMed ID: 17007963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ganglioside metabolism in a transgenic mouse model of Alzheimer's disease: expression of Chol-1α antigens in the brain.
    Ariga T; Yanagisawa M; Wakade C; Ando S; Buccafusco JJ; McDonald MP; Yu RK
    ASN Neuro; 2010 Oct; 2(4):e00044. PubMed ID: 20930939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1aα.
    Ariga T; Itokazu Y; McDonald MP; Hirabayashi Y; Ando S; Yu RK
    ASN Neuro; 2013 May; 5(2):141-8. PubMed ID: 23565921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
    Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
    J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.
    Grimm MO; Zinser EG; Grösgen S; Hundsdörfer B; Rothhaar TL; Burg VK; Kaestner L; Bayer TA; Lipp P; Müller U; Grimm HS; Hartmann T
    PLoS One; 2012; 7(3):e34095. PubMed ID: 22470521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of brain ganglioside acetylation patterns in mice with altered ganglioside biosynthesis.
    Mlinac K; Fabris D; Vukelić Z; Rožman M; Heffer M; Bognar SK
    Carbohydr Res; 2013 Dec; 382():1-8. PubMed ID: 24140892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer's disease.
    Dodge JC; Tamsett TJ; Treleaven CM; Taksir TV; Piepenhagen P; Sardi SP; Cheng SH; Shihabuddin LS
    Alzheimers Res Ther; 2022 Feb; 14(1):19. PubMed ID: 35105352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial Lipidomics Reveals Region and Long Chain Base Specific Accumulations of Monosialogangliosides in Amyloid Plaques in Familial Alzheimer's Disease Mice (5xFAD) Brain.
    Kaya I; Jennische E; Dunevall J; Lange S; Ewing AG; Malmberg P; Baykal AT; Fletcher JS
    ACS Chem Neurosci; 2020 Jan; 11(1):14-24. PubMed ID: 31774647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-lipid homeostasis in a prodromal rat model of Alzheimer's disease: Characteristic profiles in ganglioside distributions during aging detected using MALDI imaging mass spectrometry.
    Caughlin S; Maheshwari S; Agca Y; Agca C; Harris AJ; Jurcic K; Yeung KK; Cechetto DF; Whitehead SN
    Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1327-1338. PubMed ID: 29545134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gangliosides in nervous system development, regeneration, and pathologies.
    Vasques JF; de Jesus Gonçalves RG; da Silva-Junior AJ; Martins RS; Gubert F; Mendez-Otero R
    Neural Regen Res; 2023 Jan; 18(1):81-86. PubMed ID: 35799513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides in the brain in adult Down's syndrome and Alzheimer's disease.
    Brooksbank BW; McGovern J
    Mol Chem Neuropathol; 1989 Dec; 11(3):143-56. PubMed ID: 2534985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PS dependent APP cleavage regulates glucosylceramide synthase and is affected in Alzheimer's disease.
    Grimm MO; Hundsdörfer B; Grösgen S; Mett J; Zimmer VC; Stahlmann CP; Haupenthal VJ; Rothhaar TL; Lehmann J; Pätzold A; Zinser EG; Tanila H; Shen J; Müller U; Grimm HS; Hartmann T
    Cell Physiol Biochem; 2014; 34(1):92-110. PubMed ID: 24977484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant ganglioside composition in glioblastoma multiforme and peritumoral tissue: A mass spectrometry characterization.
    Fabris D; Rožman M; Sajko T; Vukelić Ž
    Biochimie; 2017 Jun; 137():56-68. PubMed ID: 28286312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization.
    Vukelić Z; Kalanj-Bognar S; Froesch M; Bîndila L; Radić B; Allen M; Peter-Katalinić J; Zamfir AD
    Glycobiology; 2007 May; 17(5):504-15. PubMed ID: 17293353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-defined quantitative snapshots of the ganglioside lipidome using high resolution ion mobility SLIM assisted shotgun lipidomics.
    Wormwood Moser KL; Van Aken G; DeBord D; Hatcher NG; Maxon L; Sherman M; Yao L; Ekroos K
    Anal Chim Acta; 2021 Feb; 1146():77-87. PubMed ID: 33461722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Moxibustion improves learning-memory ability by promoting cellular autophagy and regulating autophagy-related proteins in hippocampus and cerebral cortex in APP/PS1 transgenic Alzheimer's disease mice].
    Zhu CF; Zhang LD; Song XG; Yang J; Pan HP; He CG; Yang K; Qin XF; Zhu WL
    Zhen Ci Yan Jiu; 2019 Apr; 44(4):235-41. PubMed ID: 31056874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling of
    Cavdarli S; Yamakawa N; Clarisse C; Aoki K; Brysbaert G; Le Doussal JM; Delannoy P; Guérardel Y; Groux-Degroote S
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31935967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
    Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
    J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.